{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:25:02Z","timestamp":1748665502204,"version":"3.37.3"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,24]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Castleman\u2019s disease (CD), especially multicentric CD (MCD) has been known to manifest a variety of clinical features such as fatigue, anaemia, fever, and hypergammaglobulinaemia. Here, we report a 72-year-old female patient who had complicated severe synovitis, as an initial manifestation of the disease, lastly diagnosed as MCD. Initially, she had been diagnosed as remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome because of bilateral leg pitting oedema with significant C-reactive protein and matrix metalloproteinase-3 elevation but no disease-specific autoantibodies. Promptly, corticosteroid and additionally weekly methotrexate were introduced, but her leg oedema and inflammatory findings did not adequately come to be a remission. A lymph node biopsy from the groin region was performed because multiple lymph node swelling in ultrasound examination appeared even after introducing treatments, which revealed mixed-type CD. Multiple lymphadenopathies were observed in the axilla and inguinal region; finally, we diagnosed her as idiopathic MCD and introduced tocilizumab, which significantly improved leg oedema as well as inflammatory findings. As is shown in this case, manifestations included in RS3PE syndrome could be one of the clinical phenotypes in MCD, which should be considered as a differential diagnosis of MCD.<\/jats:p>","DOI":"10.1093\/mrcr\/rxac003","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T17:01:26Z","timestamp":1643475686000},"page":"309-313","source":"Crossref","is-referenced-by-count":1,"title":["A patient with Castleman\u2019s disease initially manifesting symmetrical synovitis with pitting oedema"],"prefix":"10.1093","volume":"6","author":[{"given":"Junichi","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-991X","authenticated-orcid":false,"given":"Yoshiyuki","family":"Arinuma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Matsueda","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Kanayama","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hoshiyama","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Tono","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Oku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"2022062410211345900_R1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJM195401072500107","article-title":"CASE records of the Massachusetts general hospital weekly clinicopathological exercises: case 40011","volume":"250","author":"Cabot","year":"1954","journal-title":"N Engl J Med"},{"key":"2022062410211345900_R2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman disease","volume":"32","author":"Wu","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2022062410211345900_R3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13730-020-00511-8","article-title":"Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab","volume":"10","author":"Furutera","year":"2021","journal-title":"CEN Case Rep"},{"key":"2022062410211345900_R4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018978","article-title":"AA amyloidosis associated with Castleman disease: a case report and review of the literature","volume":"99","author":"Bernabei","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2022062410211345900_R5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5761\/atcs.cr.12.02165","article-title":"A case of Castleman\u2019s disease with myasthenia gravis","volume":"20","author":"Ishikawa","year":"2014","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2022062410211345900_R6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Norihiro","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2022062410211345900_R7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/14397595.2017.1366093","article-title":"Tentative diagnostic criteria and disease severity classification for Castleman disease: a report of the research group on Castleman disease in Japan","volume":"28","author":"Fujimoto","year":"2018","journal-title":"Mod Rhumatol"},{"key":"2022062410211345900_R8","first-page":"404","article-title":"RS3PE revisited: a systematic review and meta-analysis of 331 cases","volume":"34","author":"Karmacharya","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2022062410211345900_R9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/ard.2004.032995","article-title":"RS3PE syndrome presenting as vascular endothelial growth factor associated disorder","volume":"64","author":"Arima","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2022062410211345900_R10","first-page":"91","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in Nagano, Japan: clinical, radiological, and cytokine studies of 13 patients","volume":"22","author":"Oide","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"2022062410211345900_R11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-013-1605-6","article-title":"Putative effects of potentially anti-angiogenic drugs in rheumatic diseases","volume":"70","author":"Maruotti","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"2022062410211345900_R12","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/1756-185X.13723","article-title":"Tocilizumab monotherapy for polymyalgia rheumatica: a prospective, single-center, open-label study","volume":"22","author":"Kentaro","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2022062410211345900_R13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/14397595.2016.1192744","article-title":"Clinical outcomes in the first year of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome","volume":"27","author":"Origuchi","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2022062410211345900_R14","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"key":"2022062410211345900_R15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00296-009-0885-8","article-title":"IL-6\/sIL-6R trans-signalling, but not TNF-\u03b1 induced angiogenesis in a HUVEC and synovial cell co-culture system","volume":"29","author":"Hashizume","year":"2009","journal-title":"Rheumatol Int"},{"key":"2022062410211345900_R16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Fajgenbaum overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"2022062410211345900_R17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015237","article-title":"Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease","volume":"98","author":"Otsuka","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxac003\/42594897\/rxac003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/6\/2\/309\/44245213\/rxac003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/6\/2\/309\/44245213\/rxac003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T10:22:07Z","timestamp":1656066127000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/6\/2\/309\/6517366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,29]]},"published-print":{"date-parts":[[2022,6,24]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxac003","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,1,29]]}}}